✦ LIBER ✦

European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

✍ Scribed by Hoenigl, M.; Strenger, V.; Buzina, W.; Valentin, T.; Koidl, C.; Wolfler, A.; Seeber, K.; Valentin, A.; Strohmeier, A. T.; Zollner-Schwetz, I.; Raggam, R. B.; Urban, C.; Lass-Florl, C.; Linkesch, W.; Krause, R.

Book ID: 117998696
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 135 KB
Volume: 67
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/dks155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and radiologic predictors of in

Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients : Should the European Organization for Research and Treatment of Cancer/Mycosis Study Group (EORTC/MSG) criteria be revised?

✍ Ray Hachem; David Sumoza; Hend Hanna; Essam Girgawy; Mark Munsell; Issam Raad 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

Phase II study of pirarubicin (THP) in p

Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC)

✍ Chauvergne, J.; Fumoleau, P.; Cappelaere, P.; Metz, R.; Armand, J.P.; Chevallier 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 683 KB

The significance of isolation of saproph

The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer : How do the European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria apply?

✍ Michail S. Lionakis; Dimitrios P. Kontoyiannis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 3 views

## Abstract ## BACKGROUND Invasive infections caused by molds other than __Aspergillus__, __Fusarium__, and __Zygomycetes__ have been reported sporadically in patients with leukemia and allogeneic bone marrow transplantation (BMT). However, the significance of lower respiratory tract cultures that

Fotemustine in patients with advanced ga

Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European organization for research and treatment of cancer, gastrointestinal tract cancer cooperative group)

✍ Ph. Rougier; C. Van Pottelsberghe; T. Kok; B. Paillot; T. Wagener; J. De Greve; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 220 KB

UFT and leucovorin in first-line chemoth

UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial

✍ A. Ravaud; M. Borner; J.H.M. Schellens; L. Geoffrois; B.P. Schöffski; K. Kroon; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Phase II trial with ISIS 5132 in patient

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

✍ B Coudert; A Anthoney; W Fiedler; J.P Droz; V Dieras; M Borner; J.F Smyth; R Mor 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 93 KB